IL6 and breast carcinoma: One of the major pathways to increased pStat3 levels in breast cancer cells involves IL-6 [48]; thus, the studies summarized above provide a possible mechanism to explain our finding of increased pStat3 levels in breast cancers expressing increased levels of Stat3β.